Company name | Market Cap | Capital Allocation score | ROIC | ROIC - WACC | CROIC | ROE | ROCE | Shares count growth | Shareholder yield |
$1,440.8M | 5.6 | 3.7% | (5.1%) | 33.8% | 4.0% | 2.3% | 5.2% | 0.0% | |
$303.8B | 6.0 | 9.0% | 0.5% | 10.5% | 7.1% | 7.1% | (0.9%) | 1.7% | |
$267.5B | 6.5 | 9.4% | (1.0%) | 19.6% | 10.4% | 8.1% | (1.7%) | 3.5% | |
$168.1B | 6.1 | 18.9% | 9.6% | 60.8% | 13.8% | 8.9% | 0.6% | 0.5% | |
$163.6B | 6.2 | 13.3% | 3.2% | 23.8% | 16.8% | 12.8% | (0.6%) | 2.0% | |
$150.8B | 7.2 | 56.9% | 46.7% | 45.4% | 50.4% | 22.9% | 2.2% | 0.8% | |
$120.1B | 6.7 | 67.0% | 55.6% | 123.5% | 18.6% | 7.4% | 0.3% | 0.0% | |
$85.1B | 7.1 | 49.8% | 38.5% | 55.4% | 155.6% | 39.7% | (0.1%) | 1.6% | |
$64.7B | 6.1 | 4.2% | (6.6%) | 31.2% | 6.0% | 2.4% | (1.3%) | 1.1% | |
$63.6B | 6.4 | 24.3% | 15.1% | 26.8% | 22.9% | 13.4% | 1.2% | 1.2% | |
$54.4B | 5.4 | (4.6%) | (16.0%) | (142.3%) | (10.6%) | (4.3%) | 28.6% | N/A |
The Enfusion, Inc. (ENFN) ROIC is 3.7%, compared to the industry median of ((0.4%)) and the 5-year historical average of (171.5%).
The Enfusion, Inc. (ENFN) ROIC minus WACC is (5.1%), compared to the industry median of ((8.8%)) and the 5-year historical average of (179.0%).
The Enfusion, Inc. (ENFN) ROE is 4.0%, compared to the industry median of (2.8%) and the 5-year historical average of (26.9%).
The Enfusion, Inc. (ENFN) ROCE is 2.3%, compared to the industry median of ((0.7%)) and the 5-year historical average of (69.9%).